MetLife Investment Advisors »

Humacyte shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $99k 35k 2.84
2023-09-30 $102k 35k 2.93
2023-06-30 $100k 35k 2.86
2023-03-31 $108k 35k 3.09
2022-12-31 $74k 35k 2.11